" class="no-js "lang="en-US"> Alexandre Chau - Medtech Alert
Tuesday, September 16, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Alexandre Chau

Alexandre Chau

About Alexandre Chau

Mr. Chau has served as CEO of Endo Tools Therapeutics since 2012. He joined the company in 2011. From 2008 to 2011, he was a strategy consultant at McKinsey & Company where he served multiple technology clients in several European countries. Mr. Chau holds a PhD and a MSc in engineering, majoring in mechanics, from the Université libre de Bruxelles (ULB).

Related Story

Clinical Trials

 Endo Tools Therapeutics Receives Positive Opinion From French High Authority for Health on Forfait Innovation Scheme to Treat Patients With Diabetes | Pharmtech Focus

Endo Tools Therapeutics Receives Positive Opinion From French High Authority for Health on Forfait Innovation Scheme to Treat Patients With Diabetes

June 14 2022

Endo Tools Therapeutics (ETT), a company developing advanced endoscopic medical devices, today announces that HAS, […]